WO1996005233A1 - Low-molecular-weight acetylated hyaluronic acid, emollient, and processes for producing and purifying the acid - Google Patents
Low-molecular-weight acetylated hyaluronic acid, emollient, and processes for producing and purifying the acid Download PDFInfo
- Publication number
- WO1996005233A1 WO1996005233A1 PCT/JP1995/001613 JP9501613W WO9605233A1 WO 1996005233 A1 WO1996005233 A1 WO 1996005233A1 JP 9501613 W JP9501613 W JP 9501613W WO 9605233 A1 WO9605233 A1 WO 9605233A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hyaluronic acid
- acid
- acetylated hyaluronic
- acetylated
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
Definitions
- the present invention relates to low molecular weight acetylated hyaluronic acid, an emollient and a method for producing the same. Regarding improvement.
- Hyaluronic acid is a high molecular substance derived from living organisms, has specific physical properties such as high viscosity, viscoelasticity, and spinnability, and has high biocompatibility. Is expected.
- the extremely high moisturizing property of hyaluronic acid is a remarkable physical property, and it is used as a moisturizing agent in various external preparations for skin, and is also used as a thickener in organic solvent systems and various in oily bases. It is expected to be used as an emulsion stabilizer, a liposome coating enhancer, a base for embedding in living bodies, and a capsule base.
- hyaluronic acid has various unique physical properties, and due to some of its properties, large amounts of hyaluronic acid may significantly impair the usability of the product. Was.
- Hyaluronic acid was strongly water-soluble and could not be used as a humectant in organic solvents or oily bases.
- the present invention has been made in view of the above-mentioned problems of the prior art, and a first object of the present invention is to provide an inexpensive acetylated hyaluronic acid that retains the inherent functions of hyaluronic acid and has various unique physical properties. It provides a production method and a purification method, and a second object is hyaluronan.
- An object of the present invention is to provide a low-molecular-weight acetylated hyaluronic acid capable of exhibiting an excellent softening effect on skin while improving defects such as spinnability of an acid.
- the low molecular weight acetylated hyaluronic acid according to the present application is characterized by having the following properties.
- the emollient of the present application contains low-molecular-weight acetylated hyaluronic acid as a main component.
- the method for producing acetylated hyaluronic acid comprises suspending powdered hyaluronic acid in an acetic anhydride solvent, and further adding concentrated sulfuric acid to acetylate the acetylated hyaluronic acid. It is characterized by obtaining acid.
- diacetic acid is mixed with the acetic anhydride solvent, and the mixing ratio of acetic acid: acid anhydride is 1: 4 to 1: 1.
- the mixing ratio of acetic acid: acid anhydride is 1: 4 to 1: 1.
- acetic acid is mixed with the anhydrous dianhydride solvent, and the mixing ratio of acetic acid: acid anhydride is preferably from 2: 1 to 4: 1. In this case, the progress of acetylation is moderated, and fine adjustment of the acetylation rate is easy.
- acetylated hyaluronic acid in the method for purifying acetylated hyaluronic acid according to the present invention, a crude acetylated hyaluronic acid is added to an aqueous solution of acetone, sodium lactate is added and dissolved, and then a high concentration acetate is added. To obtain high-purity acetylated hyaluronic acid by adding You.
- the sodium lactate is added in an amount of 1 to 3% by weight based on the aqueous solution of acetate.
- the low-molecular-weight S-acetylated hyaluronic acid according to the present invention has a structure represented by the following structural formula 1.
- the intrinsic viscosity is 50 cm s / g or less, it is difficult to obtain the skin softening effect of acetylated hyaluronic acid. If it is more than 200 cm 3 / g, undesirable physical properties such as spinnability cannot be sufficiently suppressed by acetylation.
- the degree of acetylation is represented by the number of acetyl substitutions, it is preferably from 2.6 to 3.6.
- the hyaluronic acid has the structure shown in the above-mentioned structural formula 1. There are four alcoholic hydroxyl groups in the repeating unit, and the number of acetyl groups substituted is used here as the number of acetyl groups substituted.
- the hydrophobicity tends to be insufficiently imparted. If the number exceeds 3.6, the hydrophilicity may be reduced and the usability may be deteriorated.
- Japanese Patent Application Laid-Open No. 3-143540 discloses an emulsion stabilizer in which an acyl group such as acetylation is introduced into a repeating unit of hyaluronic acid.
- the modification ratio of this hyaluronic acid derivative is extremely low, and the ratio of the acyl group ZN-acetyl group is less than a fraction. That is, only one or more tens of repeating units are introduced with one acyl group, and the effect of the present invention cannot be obtained.
- the function as an emulsifier cannot be effectively achieved unless a highly oily acyl group such as a valmityl group is introduced.
- Japanese Patent Application Laid-Open No. 6-97007 discloses a method for producing highly acetylated hyaluronic acid. This production method is excellent in that a high acetylation rate can be obtained under mild conditions.On the other hand, since an expensive drug is used, a simpler and less expensive method for producing acetylated hyaluronic acid is required. Was done.
- acetylated hyaluronic acid is suitably produced as follows.
- powdery hyaluronic acid is suspended in an anhydrous acid solvent, and concentrated sulfuric acid is added to acetylate.
- acetic acid is mixed with the acetic anhydride solvent, and the mixing ratio of sulfuric acid: acetic anhydride is preferably 1: 4 to 1: 1.
- the mixing ratio of sulfuric acid: acetic anhydride is preferably 1: 4 to 1: 1.
- a low molecular weight acetylated hyaluronic acid having a high acetylation rate can be obtained.
- the degree of acetyl group substitution can be finely adjusted. It is preferable to add 2 to 7% by volume of concentrated sulfuric acid to the solvent.
- acetylated hyaluronic acid in order to purify the characteristic acetylated hyaluronic acid in the present invention, a crude acetylated hyaluronic acid is added to an aqueous solution of acetone and sodium lactate is added and dissolved. By adding acetone, high-purity acetylated hyaluronic acid can be obtained.
- the sodium lactate be added in an amount of 1 to 3% by weight based on the aqueous solution of acetate.
- hyaluronic acid means hyaluronic acid and hyaluronic acid salt, and those having various molecular weights can be used.
- acetylation rates ranging from oligohyaluronic acid to a molecular weight of 10, OOO kd or more can be obtained by enzymatic treatment with hyaluronidase.
- An acid can be obtained, and the modification ratio can be changed by changing the esterification reaction time.
- sodium lactate is added for the purpose of precipitating acetylated hyaluronic acid by its salting out effect. That is, for example, sodium lactate is previously dissolved in an aqueous 80% aqueous solution of acetylated hyaluronic acid that is soluble. When acetone is further added to raise the acetone to 92%, the acetylated hyaluronic acid precipitates as a gel precipitate.
- the salts used for prayer include sodium acetate, sodium citrate, sodium glutamate, sodium chloride, and pyrrolidocarbonate. Examination of sodium, sodium tartrate, glycine, magnesium sulfate, and potassium chloride showed that sodium acetate had some salting-out effect, but other substances did not. Had little effect, while sodium lactate had an extremely good effect.
- the purification method according to the present invention utilizes the unique solvent solubility of acetylated hyaluronic acid produced by the above-mentioned production method, and in particular, by combining the production method and the purification method according to the present invention. As a result, high-purity acetylated hyaluronic acid can be obtained in good yield.
- the recovery of acetylated hyaluronic acid can be improved by increasing the amount of sodium lactate. Removal May be difficult. For this reason, the amount of acetonated hyaluronic acid is controlled when the acetylated hyaluronic acid is precipitated as a gel-like precipitate due to an increase in the degree of acetylation of hyaluronic acid.
- the method for producing acetylated hyaluronic acid according to the present invention can prepare acetylated hyaluronic acid at a low cost.
- the method for purifying acetylated hyaluronic acid according to the present invention can efficiently purify acetylated hyaluronic acid.
- the acetylated hyaluronic acid obtained as described above has remarkably different physical properties depending on viscosity, modification ratio, etc., and those with high viscosity and moderate modification have a small amount of organic solvent. It is expected to be used as a cosmetic base or as a base for drug delivery systems, such as the formation of a more stable gel by the addition of water.
- those having high viscosity and high acetylation and those having low viscosity are soluble in organic solvents having a considerable concentration and can be easily blended in emulsions and the like.
- it can exert various effects such as increasing the smoothness during use, and if the fat solubility is increased by acetylation, the surface becomes lipid
- the affinity with the stratum corneum, which is a membrane, is increased, and biocompatibility can be improved.
- the highly acetylated hyaluronic acid according to the present invention has an advantage that, when incorporated in cosmetics or the like, the spinnability, which is a disadvantage of hyaluronic acid, is significantly reduced.
- the emollient of the present invention may contain various components, which are generally compounded in an external preparation for skin, as necessary, in addition to the above-mentioned constituents.
- these components include liquid paraffin, scorane, lanolin derivatives, higher alcohols, various ester oils, silicone oils, and polyalkylene glycol polyethers.
- oils such as terpene-based hydrocarbon oils, surfactants, ultraviolet absorbers, ultraviolet light scattering agents, acryl-based resins, silicone resins, polyvinylpyrrolidone Resins such as soy protein, gelatin, collagen, silk fiber mouth, elastin, or protein degradation products, ethylparaben, butylparaben, etc.
- activators such as biotin and pantothenic acid derivatives, diluents such as ethanol, isopropanol, and tetrachlorodifluoroethane, thickeners such as carboxyvinyl polymer, chelating agents, oxidation Examples include an inhibitor, a moisturizer, a drug, a fragrance, and a coloring agent.
- FIG. 1 is an explanatory diagram showing the relationship between the acetylation reaction time and the intrinsic viscosity when the solvent ratio between acetic acid and acetic anhydride is changed in the method for producing acetylated hyaluronic acid according to the present invention
- FIG. 2 is an explanatory diagram showing the relationship between the acetylation reaction time and the degree of acetyl group substitution when the solvent ratio between acetic acid and anhydrous anhydride is changed in the method for producing acetylated hyaluronic acid according to the present invention
- FIG. 3 is an explanatory diagram showing the relationship between the acetylation reaction time and the intrinsic viscosity when the amount of the reaction catalyst (concentrated sulfuric acid) is changed in the method for producing acetylated hyaluronic acid according to the present invention
- FIG. 4 is an explanatory diagram showing the relationship between the acetylation reaction time and the acetyl group substitution degree when the reaction catalyst amount (concentrated sulfuric acid) is changed in the method for producing acetylated hyaluronic acid according to the present invention
- FIG. 5 is an explanatory diagram showing the spinning length of the acetylated hyaluronic acid according to the present invention.
- FIG. 6 is an explanatory diagram showing the water evaporation rate of the acetylated hyaluronic acid according to the present invention.
- FIG. 7 is an explanatory diagram showing the keratin softening effect of the acetylated hyaluronic acid according to the present invention.
- Production Example 1 Method for producing acetylated hyaluronic acid
- Acid, Shiseido Co., Ltd. fine powder is added little by little while stirring.
- the reaction liquid becomes a viscous white liquid.
- step 3 Put the purified water in step 2 into a glass beaker of 1 volume in advance, and slowly add the above reaction mixture to form a thread while stirring. The resulting precipitate of acetylated hyaluronic acid is collected, and the precipitate is further washed twice with 21 purified water in the same manner. Transfer the precipitate to an 11-volume glass beaker, add 250 ml of an 80% (v / v) aqueous solution of acetate and 9 g of a 50% aqueous solution of sodium lactate, and stir. Dissolve the precipitate completely. Subsequently, 400 ml of acetate is slowly added to re-precipitate the gel-like precipitate of acetylated hyaluronic acid.
- the present inventors set the acetylation reaction time when the ratio of the acid to acetic anhydride was changed under basically the same conditions as in Production Example 1, and the limit of the acetylated hyaluronic acid produced. The relationship between viscosity and the number of acetyl substituents was examined.
- Fig. 1 The relationship with the intrinsic viscosity is shown in Fig. 1, and the relationship with the acetyl group substitution number is shown in Fig. 2.
- the number of acetyl group substitutions depends on the number of reaction initiations, especially after 1 hour. Rises sharply within. On the other hand, the viscosity drops rapidly until about 5 to 10 hours after the start of the reaction. Therefore, the reaction time is set to 1 hour or less to obtain a high-viscosity acetylated hyaluronic acid, and the reaction time is set to 5 to 10 to obtain a low-viscosity acetylated hyaluronic acid. It is preferable to make it longer in the time range.
- the progress of acetylation is slightly improved with a slight mixing of octanoic acid as compared with the case of acetic anhydride alone, and especially with a ratio of acetic acid to acetic anhydride of about 1: 4.
- the acetylation proceeds more efficiently, and the acetylation progress and the viscosity reduction are almost the same as those of acetic anhydride alone even when the ratio of acetic anhydride to acetic anhydride is about 1: 1.
- the solvent ratio of acetic acid to acetic anhydride for efficiently proceeding acetylation is particularly preferably 1: 4 to 1: 1.
- the ratio of acetic acid to acetic anhydride is set to be about 1: 2 to 4: 1, so that the variation of the number of acetyl substituents over time is reduced. , Easy to adjust. Changes in the amount of reaction catalyst
- Sulfuric acid acts as a catalyst for promoting the acetylation of hyaluronic acid, and the amount of this reaction catalyst also affects the intrinsic viscosity of the acetylated hyaluronic acid produced and the number of acetyl substituted groups.
- the relationship between the limiting viscosity (FIG. 3) and the number of substituted acetyl groups (FIG. 4) when the amount of sulfuric acid was changed was examined.
- a filter paper (No. 2) was uniformly impregnated with 0.5 ml of a 1% aqueous solution of the test solution, and dried overnight under reduced pressure at room temperature. Next, the filter paper was adhered to the opening of a plastic petri dish containing 5 ml of water, and the change in weight over time was performed in a constant temperature and humidity chamber (temperature: 25 ° C, relative humidity: 50%). It was measured. The weight of the sample solution decreases in proportion to the time when left for a certain period of time. Therefore, the weight of the test sample is plotted against the test sample with respect to the standing time, and the slope of the approximation line is defined as the water evaporation rate constant k (mg / min). The effect was evaluated. In other words, the smaller the value of k, the higher the occlusion effect. (Skin) g Softening test
- the stratum corneum collected from the back of the guinea pig by heat-tribsine treatment was cut into 2 x 30 mm sections. This was set on a continuous dynamic viscoelasticity measurement device (manufactured by Toyo Seiki Co., Ltd., Shiseido Co., Ltd.), and the elastic modulus was measured every three minutes three times over time, and the average was used as the elasticity before application of the test solution. The ratio was measured. Next, the test solution 21 was applied on the stratum corneum, spread to a width of 3 to 4 mm, and similarly measured over time for 2 hours, and the softening effect of the stratum corneum was evaluated by the ratio to the elastic modulus before application of the test solution. That is, the smaller the value of the elastic modulus ratio, the higher the keratin softening effect.
- Test liquid 1 molecular weight 1 2 00000 hyaluronic Nsan'na Application Benefits um (HA) () 2% aqueous test solution 2:. Intrinsic viscosity 1 7 0 cm 3 / g, Asechiru group substitution number 2. 7 Low molecular weight acetyl sodium sodium hyaluronate 0.2% aqueous solution
- Test liquid 3 Intrinsic viscosity 160 cm 3 / g, acetyl group substitution number 2.8 Low molecular weight sodium acetyl hyaluronate 0.2% aqueous solution
- Test solution 4 Intrinsic viscosity: 140 cm 3 / g, acetyl group substitution: 2.9 low molecular weight sodium acetylated hyaluronate 0.2% aqueous solution
- Test liquid 5 Intrinsic viscosity: 120 cm 3 / g, low molecular weight sodium acetylated hyaluronate 0.2% aqueous solution containing 3.0 acetyl groups
- Test solution 6 Intrinsic viscosity 110 cm 3 / g, acetyl group substitution number 3.1 Low molecular weight sodium acetylated hyaluronate 0.2% aqueous solution
- Test solution 7 Intrinsic viscosity 100 cm 3 / g, acetyl group substitution number 3.2 Low molecular weight sodium acetylated hyaluronate 0.2% aqueous solution
- the aqueous solution of sodium hyaluronate has a spinning length of about 2. () cm.
- the length of each of the aqueous solutions of sodium acetylated hyaluronate is in the range of 0.1 to 0.4 cm, and that of sodium hyaluronate. It is significantly shorter than aqueous solutions. From these results, it can be clearly understood that the spinnability was improved.
- the occlusion effect measurement test was performed as described above using the following test solutions.
- Test solution 1 ion exchanged water
- Test solution 2 Intrinsic viscosity 2 0 0 (: 3/8, Asechiru group substitution number 2.6 pieces of low molecular weight Asechiru arsenate Aruro Nsan'na Application Benefits um 0.2% aqueous
- Test liquid 3 Intrinsic viscosity: 170 cm 3 / g, acetyl group substitution: 2.7 low-molecular-weight sodium acetylated hyaluronate 0.2% aqueous solution
- Test liquid 4 Intrinsic viscosity: 160 cm 3 / g, acetyl group substitution: 2.8 low-molecular-weight sodium acetylated hyaluronate 0.2% aqueous solution
- Test liquid 5 Intrinsic viscosity: 120 cm 3 / g, low molecular weight sodium acetylated hyaluronate 0.2% aqueous solution containing 3.0 acetyl groups
- Test solution 6 Intrinsic viscosity 100 cm 3 / g, acetyl group substitution number 3.2 Low molecular weight sodium acetylated hyaluronate 0.2% aqueous solution
- Test liquid 7 Intrinsic viscosity 90 cm 3 / g, low molecular weight acetylated sodium hyaluronate 0.2% aqueous solution with 3.4 acetyl substituents
- Test solution 8 Molecular weight 900,000 sodium hyaluronate (HA) 0.2% aqueous solution
- Test solution 9 1% aqueous propylene glycol (PG) solution
- the moisturizing effect was higher when sodium hyaluronate and propylene glycol, which are typical moisturizers, were added than ion-exchanged water. Although it is high, when acetylated sodium hyaluronate is used, it has a more superior moisturizing effect as compared with the above-mentioned sodium hyaluronate and propylene glycol. Is allowed. Skin I »Preliminary soft effect test
- Test solution 1 ion exchanged water
- Test liquid 2 Intrinsic viscosity: 120 cm s / g, low molecular weight sodium acetylated hyaluronate 0.2% aqueous solution with 3.0 acetyl substituents
- Test liquid 3 Intrinsic viscosity 110 cm 3 / g, acetyl group substitution number 3.1 Low-molecular-weight sodium acetylated hyaluronate 0.2% aqueous solution
- Test liquid 4 Intrinsic viscosity: 100 cm 3 / g, acetyl group substitution: 3.2 low-molecular-weight sodium acetylated hyaluronate 0.2% aqueous solution
- Test solution 5 0.2 million molecular weight sodium hyaluronate (HA) 0.2% aqueous solution
- Test solution 6 5% aqueous glycerin (DG) solution
- the elastic modulus ratio decreased due to water penetration into the stratum corneum until 2 () minutes after application, and the flexibility of the stratum corneum was reduced. To rise. Next, after about 30 minutes due to the elasticity caused by water evaporation, it recovers to the value before application, and furthermore, the value of water evaporation rebound slightly exceeds 1.
- the recovery value of flexibility in the aqueous solution of sodium hyaluronate was slightly lower than that in the ion-exchanged water application, but it was slightly effective, but it reached about 0.9 in about 50 minutes. The horns have recovered It is understood that the quality flexibility effect is low.
- the value was maintained at about 0.7, and the flexibility sustaining action was relatively high. .
- the evaluation of skin softness was determined by the average value of the elastic modulus ratio 60 minutes after application, taking into account the sustained effect of the stratum corneum softness.
- acetylated hyaluronic acid is much superior to hyaluronic acid, etc. in spinnability, moisturizing effect, skin softening effect and the like.
- Table 1 shows that the limiting viscosity was about 120 cm 3 , acetylated hyaluronic acid having various acetyl substituents was prepared, and the above effects were verified. 0 shown in 1
- the present inventors prepared acetylated hyaluronic acid having an acetyl group substitution number of about 3.0 and various intrinsic viscosities, and examined the effects thereof.
- Surfactant hyaluronic acid qs A softener was prepared by a conventional method.
- the evaluation effect of the panel was a smooth and comfortable feeling without slimming.
- the low-molecular-weight acetylated hyaluronic acid according to the present invention has a specific molecular weight and a specific number of acetyl-substituted groups. It can exhibit a wide softening effect and a moisturizing effect.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Description
Claims
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP95928025A EP0725083B1 (en) | 1994-08-11 | 1995-08-11 | Low-molecular-weight acetylated hyaluronic acid, emollient, and processes for producing and purifying the acid |
| US08/624,634 US5679657A (en) | 1994-08-11 | 1995-08-11 | Low molecular weight acetylhyaluronate, skin-softening composition, method of manufacturing the same, and method of purifying the same |
| DE69524197T DE69524197T2 (de) | 1994-08-11 | 1995-08-11 | Acetylierte hyaluronsäure mit niedrigem molekulargewicht; aufweichmittel und verfahren zur herstellung und reinigung dieser säure |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6/210611 | 1994-08-11 | ||
| JP21061194A JP3556975B2 (ja) | 1994-08-11 | 1994-08-11 | アセチル化ヒアルロン酸の製造方法及び精製方法 |
| JP7/186156 | 1995-06-29 | ||
| JP18615695 | 1995-06-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1996005233A1 true WO1996005233A1 (en) | 1996-02-22 |
Family
ID=26503585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP1995/001613 Ceased WO1996005233A1 (en) | 1994-08-11 | 1995-08-11 | Low-molecular-weight acetylated hyaluronic acid, emollient, and processes for producing and purifying the acid |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US5679657A (ja) |
| EP (1) | EP0725083B1 (ja) |
| DE (1) | DE69524197T2 (ja) |
| WO (1) | WO1996005233A1 (ja) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10279422A (ja) * | 1997-03-31 | 1998-10-20 | Shiseido Co Ltd | 皮膚外用剤 |
| CN102178611A (zh) * | 2011-04-22 | 2011-09-14 | 杭州珀莱雅控股股份有限公司 | 一种高珠光高泡沫的皂基洁面膏及其制备方法 |
| WO2013103056A1 (ja) * | 2012-02-10 | 2013-07-11 | 株式会社資生堂 | 水中油型乳化皮膚化粧料 |
| JP2017036338A (ja) * | 2012-02-10 | 2017-02-16 | 株式会社 資生堂 | 水中油型乳化皮膚化粧料 |
| WO2018162672A1 (en) * | 2017-03-10 | 2018-09-13 | Givaudan Sa | Improvements in or relating to organic compounds |
| CN110981991A (zh) * | 2019-12-24 | 2020-04-10 | 江苏诚信药业有限公司 | 一种乙酰化透明质酸盐的制备方法 |
| CN112341548A (zh) * | 2020-11-05 | 2021-02-09 | 江南大学 | 一种具有高保湿功效的谷物源多糖的加工方法及其应用 |
| RU2788453C2 (ru) * | 2017-03-10 | 2023-01-19 | Живодан Са | Улучшения в органических соединениях или улучшения, относящиеся к органическим соединениям |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001264817A1 (en) * | 2000-05-23 | 2001-12-17 | Exhale Therapeutics, Inc. | Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of clycosaminoglycans |
| US6673919B2 (en) * | 2001-03-30 | 2004-01-06 | Chisso Cororation | Chemically modified hyaluronic acid or salts thereof, and a process for producing thereof |
| EP1249247B1 (en) * | 2001-03-30 | 2007-02-28 | Chisso Corporation | Pharmaceutical preparation for the treatment of gynecological diseases |
| ITTS20010013A1 (it) * | 2001-06-04 | 2002-12-04 | Ct Ricerche Poly Tec H A R L S | Nuovi derivati di ialuronano. |
| JP2004262777A (ja) * | 2003-02-27 | 2004-09-24 | Shiseido Co Ltd | アセチル化ヒアルロン酸含有眼用医薬組成物 |
| EP1623715B1 (en) * | 2004-07-13 | 2012-09-19 | Charité - Universitätsmedizin Berlin | A composition comprising a pharmacologically active agent coupled to a target cell specific component, and a saponin |
| TWI597066B (zh) * | 2011-06-14 | 2017-09-01 | 資生堂股份有限公司 | 玻尿酸或其衍生物之承載薄膜及薄膜化妝料 |
| TWI561535B (en) * | 2011-10-06 | 2016-12-11 | Bvw Holding Ag | Copolymers of hydrophobic and hydrophilic segments that reduce protein adsorption |
| FR3006315B1 (fr) | 2013-05-31 | 2015-10-02 | Centre Nat Rech Scient | Microparticules et nanoparticules auto-associatives composees de proteines |
| FR3011470B1 (fr) | 2013-10-09 | 2017-01-06 | Centre Nat De La Rech Scient (Cnrs) | Composition antifongique comprenant un agent antifongique et du chitosane hydrophobise |
| FR3033134B1 (fr) * | 2015-02-27 | 2018-05-04 | Centre National De La Recherche Scientifique (Cnrs) | Particules d'acide hyaluronique pour des applications cosmetiques ou dermatologiques |
| CN109232770A (zh) * | 2018-09-07 | 2019-01-18 | 山东焦点生物科技股份有限公司 | 一种高取代度乙酰化透明质酸钠的制备方法 |
| CN109206537B (zh) * | 2018-10-10 | 2021-04-09 | 华熙生物科技股份有限公司 | 一种乙酰化透明质酸钠的制备方法及其应用 |
| CN113150184B (zh) * | 2021-04-14 | 2022-12-06 | 浙江理工大学 | 一种制备乙酰化透明质酸钠的方法 |
| CN113121721B (zh) | 2021-04-21 | 2022-02-15 | 山东焦点福瑞达生物股份有限公司 | 一种乙酰化透明质酸钠的制备方法 |
| CN114133419B (zh) * | 2021-12-21 | 2022-11-15 | 南京乐韬生物科技有限公司 | 一种低分子量乙酰化透明质酸盐及其制备方法和应用 |
| CN114939191B (zh) * | 2022-04-20 | 2023-09-08 | 华熙生物科技股份有限公司 | 一种水溶性润滑液及其制备方法和应用 |
| US20250213624A1 (en) * | 2022-06-14 | 2025-07-03 | Brian Casey | Injectable connective tissue biologic implant |
| KR102637766B1 (ko) | 2023-09-08 | 2024-02-16 | 주식회사 모이스텐 | 피부 기능 개선 효과를 갖는 생분해성 필름 및 이의 제조방법 |
| WO2025114962A1 (en) * | 2023-12-01 | 2025-06-05 | Shiseido Company, Ltd. | Cosmetic composition comprising acetylated hyaluronic acid |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03143540A (ja) * | 1989-10-26 | 1991-06-19 | Agency Of Ind Science & Technol | 新規な乳化安定剤 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2662077A (en) * | 1949-01-15 | 1953-12-08 | Searle & Co | Lower alkanoic acid esters of hyaluronic acid and the production thereof |
| JP2587268B2 (ja) * | 1988-04-18 | 1997-03-05 | チッソ株式会社 | 低粘度ヒアルロン酸又はその塩の製造方法 |
| JP3142415B2 (ja) * | 1992-04-21 | 2001-03-07 | 株式会社資生堂 | 高アセチル化率ヒアルロン酸及びその製造方法 |
-
1995
- 1995-08-11 WO PCT/JP1995/001613 patent/WO1996005233A1/ja not_active Ceased
- 1995-08-11 US US08/624,634 patent/US5679657A/en not_active Expired - Lifetime
- 1995-08-11 EP EP95928025A patent/EP0725083B1/en not_active Expired - Lifetime
- 1995-08-11 DE DE69524197T patent/DE69524197T2/de not_active Expired - Lifetime
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03143540A (ja) * | 1989-10-26 | 1991-06-19 | Agency Of Ind Science & Technol | 新規な乳化安定剤 |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10279422A (ja) * | 1997-03-31 | 1998-10-20 | Shiseido Co Ltd | 皮膚外用剤 |
| CN102178611A (zh) * | 2011-04-22 | 2011-09-14 | 杭州珀莱雅控股股份有限公司 | 一种高珠光高泡沫的皂基洁面膏及其制备方法 |
| CN102178611B (zh) * | 2011-04-22 | 2012-12-05 | 珀莱雅(湖州)化妆品有限公司 | 一种高珠光高泡沫的皂基洁面膏及其制备方法 |
| JP2017036338A (ja) * | 2012-02-10 | 2017-02-16 | 株式会社 資生堂 | 水中油型乳化皮膚化粧料 |
| JP2013177364A (ja) * | 2012-02-10 | 2013-09-09 | Shiseido Co Ltd | 水中油型乳化皮膚化粧料 |
| US9456965B2 (en) | 2012-02-10 | 2016-10-04 | Shiseido Company, Ltd. | Oil-in-water emulsified skin cosmetic |
| WO2013103056A1 (ja) * | 2012-02-10 | 2013-07-11 | 株式会社資生堂 | 水中油型乳化皮膚化粧料 |
| WO2018162672A1 (en) * | 2017-03-10 | 2018-09-13 | Givaudan Sa | Improvements in or relating to organic compounds |
| IL268682B (en) * | 2017-03-10 | 2022-07-01 | Givaudan Sa | Improvements in or relating to organic compounds |
| RU2788453C2 (ru) * | 2017-03-10 | 2023-01-19 | Живодан Са | Улучшения в органических соединениях или улучшения, относящиеся к органическим соединениям |
| US11766393B2 (en) | 2017-03-10 | 2023-09-26 | Givaudan Sa | Skin care composition comprising acetylated hyaluronic acid with degree of acetylation quantified by 2D-MR |
| AU2018232835B2 (en) * | 2017-03-10 | 2024-01-18 | Givaudan Sa | Improvements in or relating to organic compounds |
| EP4620535A3 (en) * | 2017-03-10 | 2025-10-22 | Givaudan SA | Improvements in or relating to organic compounds |
| CN110981991A (zh) * | 2019-12-24 | 2020-04-10 | 江苏诚信药业有限公司 | 一种乙酰化透明质酸盐的制备方法 |
| CN112341548A (zh) * | 2020-11-05 | 2021-02-09 | 江南大学 | 一种具有高保湿功效的谷物源多糖的加工方法及其应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| US5679657A (en) | 1997-10-21 |
| EP0725083A4 (en) | 1997-10-22 |
| DE69524197D1 (de) | 2002-01-10 |
| DE69524197T2 (de) | 2002-08-14 |
| EP0725083B1 (en) | 2001-11-28 |
| EP0725083A1 (en) | 1996-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5679657A (en) | Low molecular weight acetylhyaluronate, skin-softening composition, method of manufacturing the same, and method of purifying the same | |
| EP0216453B1 (en) | Esters of hyaluronic acid and their salts. | |
| AU631125B2 (en) | Cross-linked hyalonic acid ester polysaccharides | |
| JP3557044B2 (ja) | 皮膚柔軟化剤 | |
| JP4460617B2 (ja) | 膨潤性架橋ヒアルロン酸粉末及びその製造方法 | |
| JP2001520180A (ja) | 少なくとも1種のポリヒドロキシル化有機化合物と組み合わされた本質的に非晶質のセルロースナノフィブリルの、化粧品調合物中における使用 | |
| WO2022129403A1 (fr) | Composition comprenant des gélifiants aqueux, des tensioactifs et de l'acide ascorbique | |
| JPH069707A (ja) | 高アセチル化率ヒアルロン酸及びその製造方法 | |
| JP6000511B2 (ja) | 酸性多糖の酪酸−ギ酸混合エステル、ならびに肌用化粧品としてのその調製および使用 | |
| JP3556975B2 (ja) | アセチル化ヒアルロン酸の製造方法及び精製方法 | |
| JP2008285421A (ja) | 毛髪改質浸透剤およびこれを用いた毛髪用化粧料 | |
| JP3282729B2 (ja) | 自己架橋ゲランガム | |
| WO2023198917A1 (fr) | Hydrogels pour le comblement des tissus mous | |
| JPH03204804A (ja) | 皮膚化粧料 | |
| JP2005517051A (ja) | 両性多糖類、組成物及び用途 | |
| JP3686170B2 (ja) | 化粧料 | |
| JP2888566B2 (ja) | 化粧料 | |
| JPS6249245B2 (ja) | ||
| JP5683410B2 (ja) | 化粧料 | |
| JPH02101008A (ja) | 皮膚化粧料 | |
| JPH0672823A (ja) | 糖類のアルケニルコハク酸エステルを含有する化粧料 | |
| JPS63277608A (ja) | 皮膚および毛髪用組成物 | |
| JPH03109310A (ja) | キトサン誘導体含有化粧料 | |
| JP2010024207A (ja) | 噴霧用容器詰め液状化粧料 | |
| JP2834223B2 (ja) | 入浴剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1995928025 Country of ref document: EP |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 08624634 Country of ref document: US |
|
| WWP | Wipo information: published in national office |
Ref document number: 1995928025 Country of ref document: EP |
|
| WWG | Wipo information: grant in national office |
Ref document number: 1995928025 Country of ref document: EP |
